Top stories in gastroenterology: Acid suppressors reduce esophageal adenocarcinoma risk; Entyvio safe, effective for UC

Among the top stories in gastroenterology is research that showed patients with Barret’s esophagus who took proton pump inhibitors or histamine-2 receptor antagonists had a lower risk for developing esophageal adenocarcinoma. Entyvio safely and effectively treated ulcerative colitis in a real-world cohort of patients. Other top stories include nearly half of individuals who experience frequent heartburn said summer is when they experience the worst symptoms, the vice president of clinical development at Shire discussed the company’s current pipeline for gastrointestinal therapies, and ambulatory pediatric endoscopy appeared safe despite an increased risk for complications in some populations.

Acid suppressors reduce risk for esophageal adenocarcinoma in BE

Patients with Barrett’s esophagus who took proton pump inhibitors or histamine-2 receptor antagonists had a lower risk for developing esophageal adenocarcinoma, according to research published in Alimentary Pharmacology & Therapeutics. Read More.

Entyvio safe, effective for UC in real-world study

Entyvio safely and effectively treated ulcerative colitis in a real-world cohort of patients, according to research published in the American Journal of Gastroenterology. Read More.

Summer is the worst season for frequent heartburn

Nearly half of individuals who experience frequent heartburn said the summer is when they experience the worst symptoms, according to a survey conducted by Perrigo Pharmaceuticals. Read More.

Shire VP discusses GI pipeline, new therapy for chronic idiopathic constipation

In this exclusive video perspective from Digestive Disease Week 2018, Debra G. Silberg, MD, PhD, vice president of clinical development at Shire, discusses the company’s current pipeline for gastrointestinal therapies. Read More.

Significant adverse outcomes rare in ambulatory pediatric endoscopy

Ambulatory pediatric endoscopy appeared safe despite a somewhat increased risk for complications in some populations, according to an analysis of a large, multicenter database published in the Journal of Gastroenterology and Hepatology. Read More.